Introduction
The Ras superfamily of GTP-binding proteins are membrane-bound intracellular molecules that mediate a wide variety of cellular functions (reviewed in Lowy and Willumsen, 1993) . Ras family members, by alternating between active GTP-bound and inactive GDP-bound states, channel externally derived signals from a repertoire of cell surface receptor molecules. The Ras subfamily consists of ten evolutionarily conserved proteins that have been extensively implicated in the processes of cell growth and dierentiation (reviewed in Bos, 1997) . In addition, several of the subfamily members have been shown to be oncogenically activated in human tumors as well as possess transforming ability in cultured cells. These include H-, K-, and N-ras (Bos, 1989) , R-Ras (Saez et al., 1994; Cox et al., 1994) , TC21 (Graham et al., 1994; Huang et al., 1995) and most recently RRas3, also referred to as M-Ras (Kimmelman et al., 1997; Matsumoto et al., 1997) .
Growing evidence has suggested that members of the Ras subfamily exert their biological eects through the activation of several divergent downstream signaling cascades (reviewed in Vojtek and Der, 1998) . One of the major pathways activated by oncogenic Ras is the Raf4MEK4MAPK/ERK signaling cascade which involves the sequential activation through phosphorylation of these molecules on both serine and tyrosine residues (reviewed in Cano and Mahadevan, 1995) . The translocation of MAPK/ERK to the nucleus then ensures the expression of a host of genes that possess Ras-dependent transcriptional response elements in their promoter regions. The c-Jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK) and p38 MAP kinase have been demonstrated to modulate cellular responses to a wide variety of extracellular stimuli including mitogens, in¯ammatory cytokines, and UV irradiation (reviewed in Fuchs et al., 1998) . In most cell types examined, including ®broblasts, epithelial cells, and PC-12 cells, activation of JNK/ SAPK has been reported to promote programmed cell death (Fuchs et al., 1998) . In contrast to the pathways leading to MAPK/ERK activation, H-ras only minimally perturbs JNK/SAPK while overexpression of the constitutively activated mutants of the small Gproteins, Rac and Cdc42, leads to the robust stimulation of JNK/SAPK activity (Coso et al., 1995) . More recently, two scaolding proteins, MP1 and JIP-1, which bind to members of the MAPK/ ERK1 and JNK signaling cascades, respectively, have been identi®ed (Schaeer et al., 1998; Whitmarsh et al., 1998) . It is believed that these structural proteins play a critical role in assembling protein kinases, allowing coordinated phosphorylation events to occur eciently.
Furthermore, Ras has been demonstrated to interact directly with and stimulate the phosphatidylinositol 3-kinase (PI3-K) activity (Rodriguez-Viciana et al., 1994) . This cascade leads to the activation of the serine/threonine kinase Akt, p70 S6K , protein kinase C (PKC) and Rac1 (reviewed in Toker and Cantley, 1997) . Among these PI3-K substrates, Akt is of considerable interest since its activation plays a pivotal role in promoting survival and preventing apoptosis in several neuronal cell types (Dudek et al., 1997; Philpott et al., 1997; Eves et al., 1998) , and myc-induced apoptosis in ®broblasts (Kaumann-Zeh et al., 1997) . Finally, several signaling molecules have also been reported to be involved in Ras signaling events either through direct interaction or through indirect participation including AF6 (Yamamoto et al., 1997) , Cdc42 (Qiu et al., 1997) , Pak (Tang et al., 1997) , Rac1 (Qiu et al., 1995a) , RalA (Urano et al., 1996) , RhoA (Qiu et al., 1995b) and RhoB (Prendergast et al., 1995) .
We have recently identi®ed a new member of the Ras subfamily, R-Ras3 by database search for sequences which show high levels of similarity with the Ras-related G-protein, TC21 (Kimmelman et al., 1997) . Matsumoto et al. (1997) have also reported the cloning of M-Ras from a rat muscle cell cDNA library, which represents the rat homologue of the human RRas3 gene. R-Ras3 has the ability to induce cellular transformation in NIH3T3 cells, but this eect is less than that of oncogenic Ras (Kimmelman et al., 1997) . R-Ras3 has been shown to have only modest stimulatory eects on the transactivation of dierent nuclear response elements regulated by Ras (Kimmelman et al., 1997) . Interestingly, in contrast to other members of the Ras subfamily, R-Ras3 is not expressed in a ubiquitous fashion as its transcripts are restricted to the brain and the heart (Kimmelman et al., 1997; Matsumoto et al., 1997) . These observations led us to speculate that R-Ras3 plays an important physiological role in these tissues.
In the present report, we investigated the signaling events responsible for R-Ras3-mediated biological processes. We found that R-Ras3 activates Akt kinase activity and promotes cell survival in PC12 cells through a PI3-K dependent pathway.
Results
The ability of R-Ras3 to activate various kinase cascades Diverse intracellular signaling cascades have been shown to regulate distinct biological functions. As an initial attempt to unravel the biological function of RRas3, we examined the ability of R-Ras3 in perturbing components of several known kinase signaling pathways such as MAPK/ERK, JNK/SAPK and PI3-K. To test the ability of R-Ras3 to stimulate the MAPK pathway, transient kinase assays were performed in NIH3T3 cells by co-transfecting a hemagglutinin (HA)-tagged erk2 with a constitutively active form of R-Ras3 (R-Ras3 L71). As a positive control, parallel cultures were co-transfected with an H-Ras R12 oncogenic mutant. Exogenously expressed HA-erk2 was immunoprecipitated from total cell lysates and its ability to phosphorylate the substrate Myelin Basic Protein (MBP) was then examined. As shown in Figure 1 , RRas3 only minimally activated HA-erk2 kinase activity by approximately 5.1-fold when compared to vector control. In contrast, H-Ras R12 mutant activated HAerk2 kinase activity by approximately 69.5-fold under similar experimental conditions. Next, we examined the ability of R-Ras3 to activate the JNK/SAPK-dependent signaling cascade which has been extensively implicated in the propagation of stressinduced cellular responses. Transient kinase assays were performed in COS7 cells which have previously been shown to be more amenable to this type of analysis (Coso et al., 1995) . Accordingly, COS7 cells were co-transfected with an HA-tagged JNK together with the activated mutants of either R-Ras3 or H-Ras. As a positive control, parallel cultures were transfected with MEKKE, which represents a constitutively active upstream activator of JNK (Coso et al., 1995) . In all cases, exogenously expressed HA-JNK was immunoprecipitated and tested for its kinase activity towards its physiological substrate, c-Jun. Consistent with previously published results, H-Ras produced a modest stimulation of the JNK activity by 2.5-fold over the control (Coso et al., 1995) . Similarly, R-Ras3 showed a slight activation of JNK of approximately 3.6-fold ( Figure 2 ). As expected, MEKKE potently activated JNK by 48-fold when compared with cultures transfected with the control plasmid.
Finally, we investigated the propensity of R-Ras3 in perturbing the PI3-K dependent signaling pathway. The fact that high levels of R-Ras3 expression were observed in the brain, and that one of the PI3-K downstream substrates, Akt, has been extensively implicated in cell survival in neurons, led us to investigate the ability of R-Ras3 to stimulate the kinase activity of Akt. Very similar to the MAPK assay described above, Akt kinase assays were performed by transiently co-transfecting NIH3T3 cells with an HA-tagged Akt and either R-Ras3 or H-Ras Figure 1 Eect of activated R-Ras3 on MAPK/ERK activity. NIH3T3 cells were transiently transfected with 1.0 mg per plate of pLTR-HA-ERK2 and 3.5 mg of either R-Ras3 L71, H-Ras R12 or pCEV29-CAT. Ectopically expressed HA-ERK2 was immunoprecipitated from total cell lysates with an anti-HA antibody, and in vitro kinase assays were performed in the presence of [g 32 P]ATP and the substrate, MBP. Reactions were stopped by the addition of Laemmli buer and equal aliquots were resolved on a 14% SDS ± PAGE gel, dried and exposed to X-ray ®lms. Values represent fold stimulation over control with standard deviations (error bars) derived from triplicate plates of a typical experiment which has been performed three times with very similar results being obtained. Western blots (WB) were performed on the immunoprecipitated HA-ERK2 to ensure equal loading as well as the corresponding lysates to detect R-Ras3 and H-Ras expression activated mutants. As shown in Figure 3 , whereas HRas R12 mutant stimulated the ability of HA-Akt to phosphorylate the substrate, histone H2B by 2.6-fold, R-Ras3 displayed an 8.7-fold activation of the HA-Akt kinase activity under similar experimental conditions. As expected, the expression of a myristoylated, constitutively active form of Akt, myr-Akt, resulted in the robust phosphorylation of H2B by 88-fold in the same experiment. Taking all these data together, we conclude that R-Ras3 is a relatively weak activator of the MAPK pathway when compared with H-Ras. On the other hand, both R-Ras3 and H-Ras only modestly promote the kinase activity of JNK. Interestingly, RRas3 signi®cantly stimulates Akt kinase activity, which may play a role in mediating its biological functions.
R-Ras3 activation of Akt is PI3-K-dependent
To determine if the activation of Akt by R-Ras3 is mediated by PI3-K, we performed similar transient kinase assays in the presence of either Wortmannin or LY294002, which are speci®c inhibitors of PI3-K (Eves et al., 1998; Vlahos et al., 1994) . As shown in Figure 4a , Wortmannin blocked R-Ras3 activation of Akt in a dose dependent manner. The half-maximal level of inhibition was observed between 33 and 100 nM and near complete abrogation of Akt activation was achieved at a dose of 300 nM. Similarly, LY294002 also potently suppressed Akt activation in a dose dependent fashion with greater than 70% inhibition seen with the addition of 1 mM (Figure 4a ). To investigate if R-Ras3 mediated Akt activation was through a speci®c isoform of PI3-K, we utilized a well-characterized dominant negative mutant of the PI3-K, p85DiSH2-N. This inhibitory mutant represents the regulatory subunit of the a-isoform of PI3-K and it lacks the binding site for the p110 catalytic subunit . In addition, this p85 mutant has been shown to markedly inhibit Ras transformation in NIH3T3 cells . Consistent with the inhibition seen with the addition of Wortmannin and LY294002, the p85DiSH2-N eectively reduced the ability of R-Ras3 to activate Akt by 85% (Figure 4b ).
Since PI3-K inhibitors and dominant negative mutants were able to block R-Ras3 induced activation of Akt, we next tested the ability of R-Ras3 to activate PI3-K activity. For this, NIH3T3 cells were transfected with expression plasmids encoding both wild-type and activated forms of R-Ras3, as well as a control plasmid. After immunoprecipitation of the RRas3 proteins, the associated PI3-K activity was assessed by an in vitro kinase reaction using L-aPhosphatidylinositol (PI) as a substrate. The reaction mixtures were resolved by thin layer chromatography and the phosphorylated species was visualized by autoradiography. As shown in Figure 4c , whereas non-signi®cant levels of phosphorylated PI were detected in the immunoprecipitates of both control and wild-type R-Ras3 samples, the extent of PI phosphorylation increased by *10-fold in the immune complex of activated R-Ras3 L71. We conclude from these data that the ability of R-Ras3 to activate Akt (pCEV29-MEKKE) was used as a positive control. Cell extracts were subjected to immunoprecipitation with an anti-HA antibody and the ability of the immunoprecipitated JNK1 to phosphorylate the substrate GST-jun(79) was assessed by in vitro kinase assays. Reaction mixtures were resolved on a 14% SDS ± PAGE gel followed by autoradiography. Values represent fold stimulation over control with standard deviations (error bars) derived from triplicate plates from a representative experiment. Western blots (WB) were performed on the immunoprecipitated HA-JNK1 to ensure equal loading as well as the corresponding lysates to detect R-Ras3 and H-Ras expression An HA-tagged myristoylated form of Akt was used as a positive control. Cell extracts were subjected to immunoprecipitation with an anti-HA antibody and the ability of the immunoprecipitated HA-Akt to phosphorylate the substrate Histone H2B was examined by in vitro kinase assays. Values represent fold stimulation over control with standard deviations (error bars) derived from triplicate plates of a typical experiment which has been repeated four times with very similar results being obtained. Western blots (WB) were performed on the corresponding lysates to ensure equal loading as well as to detect R-Ras3, H-Ras, and Myr-HA-Akt expression correlates with its propensity to stimulate PI3-K activity.
R-Ras3 binds PI3-K in a GTP-dependent manner
To determine if the R-Ras3 associated PI3-K activity was mediated through an interaction between R-Ras3 and at least one of the isoforms of the lipid kinases, we performed in vitro binding assays using bacterially expressed GST-fusion protein of wild-type R-Ras3. Immobilized GST-R-Ras3 proteins were ®rst loaded with either GTP or GDP, and then equal aliquots were used in anity-binding experiments using total cell lysates from 293T cells overexpressing an HA-epitopetagged p110 (HA-p110). As shown in Figure 5a , the GTP-bound form of R-Ras3 showed a signi®cant level of HA-p110 in the protein complex, with an estimated 90% of the total overexpressed p110 being pulled-down from the cell lysates. In contrast, the GDP-bound inactive form of R-Ras3 failed to display detectable interaction with p110. In addition, HA-p110 failed to bind to an irrelevant GST-fusion protein, GST-p57(ct), under similar experimental conditions. To compare the relative abilities of R-Ras3 and H-Ras to bind to HAp110, similar binding assays were performed using GTP bound forms of both G-proteins. As shown in Figure 5b , GTP-bound R-Ras3 displayed a *sevenfold greater ability to bind to HA-p110 than H-Ras. To ensure the recombinant G-proteins used in these studies possess similar ability to bind guanine nucleotides, we loaded each GTPase with [ 35 S]GTP-gS and both H-Ras and R-Ras3 bound nucleotides with similar anity (data not shown). We conclude from all these experiments that the ability of R-Ras3 to stimulate Akt kinase activity was PI3-K dependent and most likely mediated through a direct interaction between R-Ras3 and the p110a catalytic subunit.
R-Ras3 activates Akt in PC12 cells
The ability of R-Ras3 in activating Akt and its high levels of expression in the Central Nervous System (CNS) led us to examine its biochemical and biological properties in cells of neural origin. For these studies, we utilized the PC12 cell line which is derived from a transplantable rat pheochromocytoma and upon dierentiation by NGF exhibits many properties of sympathetic neurons. These cells express detectable levels of both R-Ras3 transcripts and protein as revealed by Northern and Western blot analysis, respectively (data not shown). To measure Akt activation, assays were performed by co-transfecting RRas3 or H-Ras activated mutants together with an HAtagged c-Akt. The ectopically-expressed kinase was immunoprecipitated and subjected to Western blot analysis with a commercial antibody that speci®cally recognizes the phosphorylated active form of Akt. This method of analysis was chosen over the conventional immune-complex assays in order to increase the sensitivity of detecting the activation event in this cell line. As shown in Figure 6 , nearly identical results as seen in NIH3T3 cells were obtained, with R-Ras3 producing a consistent 5 ± 7-fold activation as compared to control. Under similar experimental conditions, H-Ras produced a twofold stimulation. As a positive control, expression of a myristoylated Akt produced a robust activation of over 20-fold. Thus, in cells of neural origin, R-Ras3 can mediate the activation of Akt.
R-Ras3 promotes cell survival in PC12 cells
The ability of R-Ras3 in activating Akt and to interact with PI3-K led us to investigate its role in promoting cell survival. For these studies, we utilized the PC12 cell line due to the fact that it is neurogenic and Akt could be activated by R-Ras3 in these cells. It is well documented that dierentiated PC12 cells undergo apoptotic cell death when NGF is removed from the culture medium. We investigated if R-Ras3 could promote survival under this apoptotic response. To accomplish this, PC12 cells were ®rst dierentiated in the presence of NGF for 5 days and subsequently transfected with various expression plasmids. In all cases, a GFP plasmid in a limiting concentration was also co-transfected as a marker for transfected cells. To trigger apoptosis, cells were rinsed extensively in serum free medium and incubated for a further 18 ± 20 h in the absence of NGF. The characteristic pyknotic nuclei Figure 5 GTP-dependent interaction of R-Ras3 and H-Ras with PI3-K. (a) GST-R-Ras3 wild-type protein was puri®ed from bacterial lysate and loaded with either GTP or GDP. The recombinant bacterial GST fusion proteins, including GSTp57(ct) (an irrelevant protein consisting of the C-terminus of p57 as a negative control) were incubated with lysates from 293T cells transfected with pCEV29-HA-PI3-K or non-transfected cells. After incubation and washing, the beads were boiled in sample buer and subjected to SDS ± PAGE analysis. Western blot analysis was performed using an anti-HA antibody to detect the presence of HA-PI3-K bound to GST-fusion proteins. Various 293T lysates were also subjected to Western blot analysis to determine the expression levels of HA-PI3-K in each sample. Additionally, an aliquot of glutathione beads with the respective GST-fusion proteins was subjected to Western analysis with an anti-GST antibody to detect the amount of each protein used for the pull down. Similar results were obtained in a repeated experiment. (b) The relative ability of R-Ras3 and H-Ras to complex with p110 was compared by performing similar assays as described above using GST-R-Ras3 and GST-H-Ras bound to GTP Figure 6 R-Ras3 activation of Akt in PC12 cells. Sub-con¯uent plates of PC12 cells grown on 15 mg/ml poly-D-Lysine were transfected with 20 mg of R-Ras3 L71 or H-Ras R12 along with 5.0 mg of HA-Akt. Cells were lysed and the HA-Akt immunoprecipitated followed by Western blot using an antibody speci®c for the activated form of Akt. Data represents duplicate plates of an experiment that was performed three times with similar results obtained. Standard deviations are represented by error bars. Western blot analysis was performed on parallel plates to detect the levels of HA-Akt, R-Ras3 L71, and H-Ras R12 with condensed chromatin were clearly evidenced ( Figure 7c, panel 1) . On average, 40 ± 60% of the GFP-positive cells showed abnormal nuclear staining as opposed to only 20% when cells were cultured in the presence of NGF (Figure 7a ). The extent of apoptosis observed resembled to the reported results derived from other previous studies (Xia et al., 1995) . More importantly, transfection of an activated R-Ras3 eectively restored cell survival to a level similar to that when NGF was present in the culture medium (Figure 7a) .
To assess whether the survival promoting ability of R-Ras3 was mediated by a PI3-K dependent signaling pathway, similar survival assays were performed with the addition of LY294002. As shown in Figure 7b and c, the addition of LY294002 almost completely restored the level of apoptosis near that of control cells. Additional experiments were performed in which the eect of LY294002 was tested on control cells incubated in the absence of NGF with no dierence in the number of apoptotic cells being observed as compared to those incubated without LY294002 (data not shown). Also, R-Ras3 transfectants as well as control cells were incubated with LY294002 in the presence of NGF with no signi®cant increase in apoptosis occurring (data not shown). Thus, the eect of LY294002 could be attributed solely to its inhibition of PI3-K and not to any non-speci®c toxic eects. Together, this data indicates that R-Ras3 allows the neuronal-like PC12 cells to subvert the normal apoptotic program in response to withdrawal of trophic support in a PI3-K dependent manner.
Discussion
Among the transforming members of the Ras subfamily, R-Ras3 displays qualitative and quantitative dierences from other G-proteins of the same class, such as, H-Ras, TC21, and R-Ras. R-Ras3 possesses the weakest transforming activity among other related Ras-like oncogenes which appears to correlate with the relative ability of each to induce the MAPK/ERK pathway. More recently, the MAPK/ERK signaling cascade has been implicated in cellular senescence evoked by oncogenic Ras, and this phenomenon could be circumvented by the loss of tumor suppressor elements such as p53, and p16
INK4a (Serrano et al., 1997) . The reduced propensity of oncogenic R-Ras3 to activate MAPK when compared with Ras would predict that this novel G-protein be unlikely to induce cellular senescence. Indeed, the expression of both the oncogenic forms of TC21 and R-Ras in primary ®broblasts failed to induce phenotypes resembling cellular senescence (Lin et al., 1998) . Accordingly, these three closely related Ras-related G-proteins may transform cells by distinct pathways other than that of MAPK/ERK. Whether activating lesions in these novel transforming genes would be preferentially selected for in certain human tumors remains to be determined.
As expected, R-Ras3 did not signi®cantly activate JNK/SAPK in transient kinase assays. This is based on the observations that none of the Ras subfamily members, namely H-Ras, TC21, R-Ras, Ral, and Rap/K-rev-1, have been shown to activate JNK/SAPK signi®cantly. It appears that this cascade is most likely The arrow indicates a transfected cell that has undergone apoptosis. All ®elds were viewed by¯uorescence microscopy at a magni®cation of 606, with panels 1 and 2 enlarged to emphasize the nuclear morphology of living and apoptotic cells involved in signaling through the RHO family of GTPases in response to externally-derived stresses. We cannot, however, exclude the possibility that other members of the JNK family, such as p38 MAPK or JNK2, or 3, could be activated by R-Ras3. In fact, such studies are warranted, due to the fact that R-Ras3 can promote cell survival in neural cells and recent reports have shown that JNK1 and 2 to be essential for proper CNS development by modulating apoptosis in a regional speci®c fashion, increasing programmed cell death in some areas while preventing it in others (Kuan et al., 1999) .
Previous studies have led to the emergence of a model of Ras transformation involving the interaction and subsequent activation of multiple downstream eectors (Vojtek and Der, 1998) . Among these, the PI3-Kdependent signaling pathway is believed to play a critical role in promoting cellular transformation. For example, a dominant negative PI3-K mutant, p85DiSH2-N, has been shown to greatly reduce the number of transformed foci induced by oncogenic Ras in NIH3T3 cells . In addition, a constitutively active PI3-K has been reported to promote cell entry into S phase of the cell cycle, and prolonged activation of PI3-K leads to morphological changes resembling those seen in oncogene-transformed cells (Klippel et al., 1998) . Akt has been extensively implicated in promoting cell survival and is a direct downstream substrate of PI3-K (Dudek et al., 1997; Philpott et al., 1997; Eves et al., 1998; Kaumann-Zeh et al., 1997) . In addition, oncogenic Ras has previously been reported to stimulate Akt kinase activity in NIH3T3 cells, and this process could be augmented by the co-expression of v-src (Datta et al., 1996) . Although both MAPK and Akt kinase assays were performed under near identical conditions, these GTPases exhibit a signi®cant disparity in stimulating these pathways. On average, R-Ras3 activates Akt by 5 ± 10-fold, whereas H-Ras achieves approximately a 2 ± 4-fold stimulation. In contrast HRas stimulated the MAPK activity approximately 70-fold, while R-Ras3 produced a ®vefold stimulation. The observed preferential activation of Akt by R-Ras3 could be explained by the higher anity binding to the 110 kDa catalytic subunit of PI3-K when compared to H-Ras. Although both R-Ras3 and H-Ras share an identical core eector-binding domain, sequences immediately¯anking this region may confer speci®city to substrate binding. The construction of R-Ras3/H-Ras chimeric molecules may help to identify regions in these G-proteins that may confer the observed biological dierences.
The dependence of R-Ras3 on PI3-K in activating Akt was clearly demonstrated by the use of the pharmacological compound, Wortmannin. The dose responsible for inhibiting 50% of Akt activation was around 33 ± 100 nM. This concentration range is consistent with those reported previously for producing 450% inhibition of Akt activation by PDGF (20 nM) (Franke et al., 1995) , v-Ha-ras/v-src (200 nM) (Datta et al., 1996) and heterotrimeric G-protein-linked receptors (50 nM) (Murga et al., 1998) . LY294002, additionally, was able to potently suppress Akt activation by R-Ras3 in similar assays, supporting the fact that the activation is most likely mediated by PI3-K. These results are consistent with a GTP-dependent interaction between R-Ras3 and the catalytic subunit of p110a, and the fact that a dominant negative PI3-K mutant, blocks over 80% of the activation event in the Akt kinase assays. Additionally, we have shown that R-Ras3 can stimulate the activity of associated PI3-K, thus ®rmly establishing the role of this pathway in R-Ras3 mediated signaling.
The biological signi®cance of R-Ras3 in activating Akt was re¯ected in its ability to prevent apoptosis in dierentiated PC12 cells upon NGF withdrawal. The anti-apoptotic eect of R-Ras3 was completely abrogated by LY294002 at a dose which was shown to block Akt kinase activation, implicating the involvement of the PI3-K pathway in R-Ras3 functions. The fact that PC12 cells when treated with LY294002 in the presence of NGF do not undergo signi®cant apoptosis is not surprising. In fact, this observation is consistent with previous reports showing that inhibition of PI3-K in both PC12 cells and primary neurons in the presence of NGF does not cause a signi®cant amount of cell death (Kimura et al., 1994; Philpott et al., 1997) . This is most likely due to NGF's ability to activate other survival pathways, such as the Ras-MAPK pathway which has been recently implicated in neuronal cell survival (Bonni et al., 1999) .
Considerable knowledge has been generated in the identi®cation of survival factors for neuronal cells. For example, sympathetic neurons such as those derived from PC12 cells and superior cervical ganglion are acutely dependent on NGF for survival (Deshmukh et al., 1997) . In addition, increases in intracellular cAMP and calcium ion levels also protect sympathetic neurons from apoptotic cell death (Rydel and Green, 1988; Collins et al., 1991) . It is highly likely that R-Ras3 may be involved in transducing one of these survival signaling events in normal physiological settings. More importantly, both H-ras and N-ras knockout mice are viable with the absence of any reported neurological defects (Umano et al., 1995) . Based on the fact that R-Ras3 is the only known member of the Ras family to show such restricted expression in the CNS, it is tempting to speculate that its function in the nervous system may supersede other related family members.
In conclusion, we have demonstrated that R-Ras3 promotes survival in PC12 cells. This biological phenomenon of R-Ras3 is most likely mediated by components of the PI3-K signaling pathway. Given the high level and exclusive expression of R-Ras3 in the CNS, it is plausible that R-Ras3 may play a critical role in the maintenance of cell viability in dierentiated neurons both during development and in adulthood.
Materials and methods

Cell lines
The NIH3T3 and COS7 cells were maintained in Dulbecco's Modi®ed Eagle's Medium (DMEM) supplemented with 10% calf serum (CS). The 293T cells were maintained in DMEM supplemented with 10% (v/v) fetal bovine serum (FBS). The rat pheochromocytoma cell line, PC12, was propagated on collagen-coated dishes in RPMI 1640 medium supplemented with 5% FBS, and 10% horse serum.
Plasmids
The construction of the constitutively active R-Ras3 mutant, R-Ras3 L71, has previously been described (Kimmelman et al., 1997) . For the construction of pCEV29-HA-PI3-K, a hemagglutinin (HA)-tag (YPYDVPDYA) was fused to the ®rst codon of the wild-type bovine p110 subunit of PI3-K by PCR-based strategy. The pCEV29-p85DiSH2-N expression plasmid was generated by excising the dominant negative p85 cDNA from pSG5-p85DiSH2-N (Rodriguez-Viciana et al., 1997) as an EcoRI fragment and cloned into the EcoRI site of pCEV29. All constructs generated by PCR were subjected to nucleotide sequencing analysis to verify authenticity. Expression plasmids used in transient immune-complex kinase assays which include the pCEV29-H-Ras R12 (Huang et al., 1995) , pLTR-HA-ERK2, pCDNAIII-HA-JNK, pCEV29-MEKKE (Coso et al., 1995) , CMV5-HA-Akt (Eves et al., 1998; Franke et al., 1995) and CMV6-myr-HA-Akt (Eves et al., 1998; Franke et al., 1995) have all been described previously.
Antibodies
The anti-R-Ras3 rabbit polyclonal antibody was raised against a fusion protein of glutathione-S-transferase (GST)-R-Ras3 (Covance). The anti-Ras monoclonal antibody, Y259, has previously been described (Lacal and Aaronson, 1986) . The anti-HA antibody was derived from the Monoclonal core facility of the Mt. Sinai School of Medicine. The anti-AU5 antibody was obtained from Covance Inc. An anti-p85 PI3-K polyclonal antibody was purchased from Upstate Biotech., and the rabbit polyclonal anti-GST antibody was generated from this laboratory. The anti-phospho Akt antibody was purchased from New England Biolabs.
MAPK kinase assay
For transient assays, 1610 6 NIH3T3 cells were transfected by standard calcium phosphate precipitation method with 1.0 mg of an HA-epitope-tagged MAPK/ERK2 expression plasmid and 3.5 mg of dierent Ras-related mutants (Coso et al., 1995) . One day after transfection, cells were placed in serum-depleted medium for 20 h and subsequent cell lysis and kinase reaction were performed as described previously (Kimmelman et al., 1997) .
JNK kinase assay
For transient assays, 1610 6 COS7 cells were transfected with 5.0 mg of each expression plasmid. The JNK/SAPK was exogenously introduced by transfecting 1.0 mg of an HAtagged JNK/SAPK expression plasmid, pCDNAIII-HA-JNK (Coso et al., 1995) . Positive control was provided by a constitutively active MEKK1 expression plasmid, pCEV29-MEKKE, which is an upstream activator of JNK/SAPK (Coso et al., 1995) . One day after transfection, cells were placed in serum-depleted medium for 2 h and subsequent cell lysis and kinase reaction were performed as previously described (Coso et al., 1995) .
Akt kinase assay
Approximately 3.0 mg of dierent Ras-related expression plasmids were co-transfected with 0.8 mg of HA-Akt expression plasmid into 5610 5 NIH3T3 cells. Approximately 24 h after transfection, cultures were rendered quiescent for 18 h in 0.3% CS and subsequent cell lysis and kinase reaction were performed as previously described (Eves et al., 1998; Franke et al., 1995) . For kinase reactions utilizing PC12 cells, a subcon¯uent plate of cells was transfected using Lipofectamine (Life Tech.) with 20 mg of H-Ras or R-Ras3 expression plasmid and 5 mg of HA-Akt. After 2 days, the cells were lysed as described above and HA-Akt was immunoprecipitated, the products subjected to SDS ± PAGE followed by Western blot using the anti-Phospho Akt antibody.
PI3-K kinase assay
Approximately 5610 5 NIH3T3 cells were transfected with 10 mg of expression vectors encoding for R-Ras3 or R-Ras3 L71 or a control plasmid. Around 18 h after transfection, cells were grown in 0.5% CS for 20 h. Cells were then solubilized in a buer composed of 20 mM Tris-HCl pH 7.5, 100 mM NaCl, 5 mM EDTA, 1 mM Na 3 VO 4 , 1% NP-40, 1 mM PMSF, 10 mg/ml Leupeptin and 10 mg/ml of Aprotinin. Approximately 1 mg of total cell lysate was used for immunoprecipitation with 1 mg of an anti-AU5 antibody to immunoprecipitate the tagged protein. The PI3-K reaction was performed as previously described (Fedi et al., 1994) . Brie¯y, immune complexes were incubated with 10 mg of L-aPhosphatidylinositol (Sigma) in a kinase reaction buer containing 20 mM Tris-HCl pH 7.5, 100 mM NaCl, and 0.5 mM EGTA. Reactions were started by the addition of 25 mM MgCl 2 and 1 mCi [g- 
In vitro binding assay
Triton X-100 soluble fusion proteins of GST-R-Ras3, GST-H-Ras, or GST-p57(ct) prepared from 300 ml of overnight bacterial cultures were coupled onto 300 ml of glutathione beads. GST-R-Ras3 was then loaded with either 1 mM of GDP or GTP in a loading buer (20 mM Tris-HCl (pH 7.5), 10 mM EDTA (pH 8), 5 mM MgCl 2 , 1 mM DTT and 1 mM PMSF) for 25 min at room temperature. Reactions were stopped by adjusting MgCl 2 to a ®nal concentration of 20 mM followed by incubation on ice for 10 min. Beads were then equilibrated in a binding buer composed of 20 mM Tris-HCl (pH 7.5), 50 mM NaCl, 6 mM MgCl 2 , 10% glycerol, and 1% NP-40. p110 PI3-K was generated by transfecting 1610 6 293T cells grown in 100 mm culture dish with 5 mg of the expression plasmid, pCEV29-HA-PI3-K. Approximately 36 h after transfection, cells were harvested in 600 ml of the binding buer as described above. Usually, lysate prepared from a 100 mm plate was used in a single binding reaction. For a typical binding reaction, 50 ml aliquots of the beads containing approximately 10 mg of nucleotide-loaded GST-RRas3, GST-H-Ras or GST-p57(ct) (an irrelevant protein) were incubated with 500 ml of 293T cell lysates. Following incubation at 48C for 2 h, binding reactions were washed four times in the same binding buer and bound proteins were eluted by boiling in Laemmli buer. The extent of HA-PI3-K binding to GST fusion proteins was then assessed by Western blot analysis using an anti-HA antibody.
Cell survival assay
Cell survival assays were performed using a modi®ed protocol of Xia et al. (1995) . Brie¯y, PC12 cells were plated at a low density on coverslips coated with poly-D-Lysine (50 mg/ml) followed by rat tail collagen and allowed to dierentiate in 1% serum in the presence of Nerve Growth Factor (NGF, 50 ng/ml). After approximately 5 days, these cells were transfected with 2.0 mg of R-Ras3 L71 expression plasmid or a control vector along with a limiting amount (0.2 mg) of a vector containing the Green Fluorescence Protein (GFP) as a marker for transfection. After 2 days, cells were rinsed four times in RPMI medium and incubated under this condition for approximately 18 ± 22 h. Cells were then stained with 4,6-diamidino-2-phenylindole (DAPI) and approximately 50 GFP-positive cells were scored for fragmented nuclear morphology.
